Samuel Saslaw, M.D., Ph.D., F.A.C.P.; Harold N. Carlisle, Ph.D.
This content is PDF only. Please click on the PDF icon to access.
Elderly people represent a high risk group in influenza virus infections and yearly vaccination with 1.0 ml of polyvalent vaccine is recommended. Studies in 1960 with 772 elderly persons (mean age, 63.8 years) showed that 1.0 ml of polyvalent vaccine subcutaneously was superior to 0.1 ml intracutaneously when given as the first injection but not as booster 3 months later. Follow-up studies in 1963 of 237 members of this group (mean age, 66.4 years) were conducted comparing H-I antibody response to 11 strains of influenza virus after 1.0, 0.5, 0.25 ml of polyvalent vaccine subcutaneously and 0.1 ml intracutaneously. Antibody
Saslaw S, Carlisle HN. Effect of Dose of Polyvalent Influenza Vaccine on Antibody Response in an Aged Population.. Ann Intern Med. ;62:1089. doi: 10.7326/0003-4819-62-5-1089_1
Download citation file:
Published: Ann Intern Med. 1965;62(5):1089.
Infectious Disease, Influenza, Prevention/Screening, Vaccines/Immunization.
Results provided by:
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use